Ex vivo human placental transfer of trovafloxacin

B. Casey, R. E. Bawdon

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective: The purpose of this study was to determine the ex vivo human placental transfer of trovafloxacin from the maternal circulation to the fetal circulation. Methods: Six placentas from uncomplicated, term, vaginal or cesarean deliveries were studied using the ex vivo isolated cotyledon perfusion chamber; 14C-antipyrine was used as a reference compound to determine the clearance index (CI) of trovafloxacin. Results: The CI of trovafloxacin was 0.19 ± 0.13 at a mean trough concentration of 1.38 ± 0.22 μg/ml and 0.16 ± 0.10 at a mean peak concentration of 7.48 ± 2.3 μg/ml as determined by our newly developed high-pressure liquid chromatographic assay. Tissue concentration did not exceed maternal concentration, and there was little or no accumulation when the perfusion system was closed for 1 hr. Conclusions: Trovafloxacin crosses the placenta by simple diffusion and does not accumulate in the media to any extent, nor does it bind to tissue or accumulate in the placenta.

Original languageEnglish (US)
Pages (from-to)228-229
Number of pages2
JournalInfectious Diseases in Obstetrics and Gynecology
Volume8
Issue number5-6
DOIs
StatePublished - 2000

Fingerprint

Placenta
Perfusion
Mothers
Antipyrine
Cotyledon
Pressure
trovafloxacin

Keywords

  • Maternal-fetal transfer
  • Trovafloxacin
  • Trovan

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Dermatology

Cite this

Ex vivo human placental transfer of trovafloxacin. / Casey, B.; Bawdon, R. E.

In: Infectious Diseases in Obstetrics and Gynecology, Vol. 8, No. 5-6, 2000, p. 228-229.

Research output: Contribution to journalArticle

Casey, B. ; Bawdon, R. E. / Ex vivo human placental transfer of trovafloxacin. In: Infectious Diseases in Obstetrics and Gynecology. 2000 ; Vol. 8, No. 5-6. pp. 228-229.
@article{92d8311ae1af4e9e87e618d01dad3669,
title = "Ex vivo human placental transfer of trovafloxacin",
abstract = "Objective: The purpose of this study was to determine the ex vivo human placental transfer of trovafloxacin from the maternal circulation to the fetal circulation. Methods: Six placentas from uncomplicated, term, vaginal or cesarean deliveries were studied using the ex vivo isolated cotyledon perfusion chamber; 14C-antipyrine was used as a reference compound to determine the clearance index (CI) of trovafloxacin. Results: The CI of trovafloxacin was 0.19 ± 0.13 at a mean trough concentration of 1.38 ± 0.22 μg/ml and 0.16 ± 0.10 at a mean peak concentration of 7.48 ± 2.3 μg/ml as determined by our newly developed high-pressure liquid chromatographic assay. Tissue concentration did not exceed maternal concentration, and there was little or no accumulation when the perfusion system was closed for 1 hr. Conclusions: Trovafloxacin crosses the placenta by simple diffusion and does not accumulate in the media to any extent, nor does it bind to tissue or accumulate in the placenta.",
keywords = "Maternal-fetal transfer, Trovafloxacin, Trovan",
author = "B. Casey and Bawdon, {R. E.}",
year = "2000",
doi = "10.1002/1098-0997(2000)8:5<228::AID-IDOG1023>3.0.CO;2-S",
language = "English (US)",
volume = "8",
pages = "228--229",
journal = "Infectious Diseases in Obstetrics and Gynecology",
issn = "1064-7449",
publisher = "Hindawi Publishing Corporation",
number = "5-6",

}

TY - JOUR

T1 - Ex vivo human placental transfer of trovafloxacin

AU - Casey, B.

AU - Bawdon, R. E.

PY - 2000

Y1 - 2000

N2 - Objective: The purpose of this study was to determine the ex vivo human placental transfer of trovafloxacin from the maternal circulation to the fetal circulation. Methods: Six placentas from uncomplicated, term, vaginal or cesarean deliveries were studied using the ex vivo isolated cotyledon perfusion chamber; 14C-antipyrine was used as a reference compound to determine the clearance index (CI) of trovafloxacin. Results: The CI of trovafloxacin was 0.19 ± 0.13 at a mean trough concentration of 1.38 ± 0.22 μg/ml and 0.16 ± 0.10 at a mean peak concentration of 7.48 ± 2.3 μg/ml as determined by our newly developed high-pressure liquid chromatographic assay. Tissue concentration did not exceed maternal concentration, and there was little or no accumulation when the perfusion system was closed for 1 hr. Conclusions: Trovafloxacin crosses the placenta by simple diffusion and does not accumulate in the media to any extent, nor does it bind to tissue or accumulate in the placenta.

AB - Objective: The purpose of this study was to determine the ex vivo human placental transfer of trovafloxacin from the maternal circulation to the fetal circulation. Methods: Six placentas from uncomplicated, term, vaginal or cesarean deliveries were studied using the ex vivo isolated cotyledon perfusion chamber; 14C-antipyrine was used as a reference compound to determine the clearance index (CI) of trovafloxacin. Results: The CI of trovafloxacin was 0.19 ± 0.13 at a mean trough concentration of 1.38 ± 0.22 μg/ml and 0.16 ± 0.10 at a mean peak concentration of 7.48 ± 2.3 μg/ml as determined by our newly developed high-pressure liquid chromatographic assay. Tissue concentration did not exceed maternal concentration, and there was little or no accumulation when the perfusion system was closed for 1 hr. Conclusions: Trovafloxacin crosses the placenta by simple diffusion and does not accumulate in the media to any extent, nor does it bind to tissue or accumulate in the placenta.

KW - Maternal-fetal transfer

KW - Trovafloxacin

KW - Trovan

UR - http://www.scopus.com/inward/record.url?scp=0034491424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034491424&partnerID=8YFLogxK

U2 - 10.1002/1098-0997(2000)8:5<228::AID-IDOG1023>3.0.CO;2-S

DO - 10.1002/1098-0997(2000)8:5<228::AID-IDOG1023>3.0.CO;2-S

M3 - Article

C2 - 11220482

AN - SCOPUS:0034491424

VL - 8

SP - 228

EP - 229

JO - Infectious Diseases in Obstetrics and Gynecology

JF - Infectious Diseases in Obstetrics and Gynecology

SN - 1064-7449

IS - 5-6

ER -